India CCI To Monitor Patent Dispute Settlements
This article was originally published in PharmAsia News
Executive Summary
The Competition Commission of India (CCI) plans to monitor patent dispute settlements between local generics makers and multinationals, such as Roche's agreement with Cipla, to ensure they do not affect a drug's price or availability.